Christensen M, Sparre-Ulrich AH, Hartmann B, et al
Panel recommendations Oral semaglutide provides an attractive option for Indian physicians, subject to overall awareness and acceptance of the drug, its use, and its benefits in T2DM patients
Research in earlier phases or small trials include evaluation of GLP-1s for indications such as cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes
PubMed Randomized trialTirzepatide evidence2025 Tirzepatide for Obesity Treatment and Diabetes Prevention Supports newer discussion of obesity treatment and diabetes-prevention outcomes